598 related articles for article (PubMed ID: 14985822)
1. Distinct beta-adrenergic receptor subtype signaling in the heart and their pathophysiological relevance.
Zheng M; Han QD; Xiao RP
Sheng Li Xue Bao; 2004 Feb; 56(1):1-15. PubMed ID: 14985822
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins.
Xiao RP
Sci STKE; 2001 Oct; 2001(104):re15. PubMed ID: 11604549
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
Devic E; Xiang Y; Gould D; Kobilka B
Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
[TBL] [Abstract][Full Text] [Related]
4. Targeted inhibition of beta-adrenergic receptor kinase-1-associated phosphoinositide-3 kinase activity preserves beta-adrenergic receptor signaling and prolongs survival in heart failure induced by calsequestrin overexpression.
Perrino C; Naga Prasad SV; Patel M; Wolf MJ; Rockman HA
J Am Coll Cardiol; 2005 Jun; 45(11):1862-70. PubMed ID: 15936620
[TBL] [Abstract][Full Text] [Related]
5. The control of cardiomyocyte apoptosis via the beta-adrenergic signaling pathways.
Communal C; Colucci WS
Arch Mal Coeur Vaiss; 2005 Mar; 98(3):236-41. PubMed ID: 15816327
[TBL] [Abstract][Full Text] [Related]
6. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.
Zhu WZ; Wang SQ; Chakir K; Yang D; Zhang T; Brown JH; Devic E; Kobilka BK; Cheng H; Xiao RP
J Clin Invest; 2003 Mar; 111(5):617-25. PubMed ID: 12618516
[TBL] [Abstract][Full Text] [Related]
7. Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure.
Port JD; Bristow MR
J Mol Cell Cardiol; 2001 May; 33(5):887-905. PubMed ID: 11343413
[TBL] [Abstract][Full Text] [Related]
8. beta(2)-Adrenergic receptor signaling complexes in cardiomyocyte caveolae/lipid rafts.
Steinberg SF
J Mol Cell Cardiol; 2004 Aug; 37(2):407-15. PubMed ID: 15276011
[TBL] [Abstract][Full Text] [Related]
9. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
10. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
11. Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart.
Pepe S; van den Brink OW; Lakatta EG; Xiao RP
Cardiovasc Res; 2004 Aug; 63(3):414-22. PubMed ID: 15276466
[TBL] [Abstract][Full Text] [Related]
12. What is the role of beta-adrenergic signaling in heart failure?
Lohse MJ; Engelhardt S; Eschenhagen T
Circ Res; 2003 Nov; 93(10):896-906. PubMed ID: 14615493
[TBL] [Abstract][Full Text] [Related]
13. RGS2 inhibits beta-adrenergic receptor-induced cardiomyocyte hypertrophy.
Nunn C; Zou MX; Sobiesiak AJ; Roy AA; Kirshenbaum LA; Chidiac P
Cell Signal; 2010 Aug; 22(8):1231-9. PubMed ID: 20362664
[TBL] [Abstract][Full Text] [Related]
14. Effects of chronic application of propranolol on beta-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters.
Witte K; Schnecko A; Hauth D; Wirzius S; Lemmer B
Br J Pharmacol; 1998 Nov; 125(5):1033-41. PubMed ID: 9846642
[TBL] [Abstract][Full Text] [Related]
15. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
[TBL] [Abstract][Full Text] [Related]
16. Receptor systems affecting force of contraction in the human heart and their alterations in chronic heart failure.
Brodde OE; Hillemann S; Kunde K; Vogelsang M; Zerkowski HR
J Heart Lung Transplant; 1992; 11(4 Pt 2):S164-74. PubMed ID: 1355362
[TBL] [Abstract][Full Text] [Related]
17. Selective enhancement of beta-adrenergic receptor signaling by overexpression of adenylyl cyclase type 6: colocalization of receptor and adenylyl cyclase in caveolae of cardiac myocytes.
Ostrom RS; Violin JD; Coleman S; Insel PA
Mol Pharmacol; 2000 May; 57(5):1075-9. PubMed ID: 10779394
[TBL] [Abstract][Full Text] [Related]
18. Adrenergic pathways and left ventricular remodeling.
Dorn GW
J Card Fail; 2002 Dec; 8(6 Suppl):S370-3. PubMed ID: 12555147
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in cardiac beta(2)-adrenergic signal transduction.
Xiao RP; Cheng H; Zhou YY; Kuschel M; Lakatta EG
Circ Res; 1999 Nov; 85(11):1092-100. PubMed ID: 10571541
[TBL] [Abstract][Full Text] [Related]
20. Myocyte adrenoceptor signaling pathways.
Xiang Y; Kobilka BK
Science; 2003 Jun; 300(5625):1530-2. PubMed ID: 12791980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
